JiHChenSHuQ, et al. Investigating the correlation between serum amyloid A and infarct-related artery patency prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction patients. Angiology. 2024;75:585-594.
2.
WebbNR. High-density lipoproteins and Serum Amyloid A (SAA). Curr Atheroscler Rep. 2021;23:7.
3.
MetwalliOHashemEAjabnoorMA,SrAlamaNBanjarZM. Study of some inflammatory mediators in the serum of patients with atherosclerosis and acute myocardial infarction. Cureus. 2021;13:e18450.
4.
ÖzkanCKarayiğitO. Relationship between high sensitivity C-reactive protein to albumin ratio with infarct-related artery patency in patients with non-ST-segment elevation myocardial infarction. Angiology. 2023;33197231176983. doi:10.1177/00033197231176983
5.
Gayretli YaylaKYaylaCErdolMAKaranfilMErtemAGAkcayAB. Relationship between C-reactive protein to albumin ratio and infarct-related artery patency in patients with ST-segment elevation myocardial infarction. Angiology. 2022;73:260-4.
6.
VallejoAChamiBDennisJM, et al.NF-κB inhibition mitigates serum amyloid A-induced pro-atherogenic responses in endothelial cells and leukocyte adhesion and adverse changes to endothelium function in isolated aorta. Int J Mol Sci. 2018;20:105.
7.
HuaSSongCGeczyCLFreedmanSBWittingPK. A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis. Redox Rep. 2009;14:187-96.
